Tenax Therapeutics Working on Phase 2 Trial

Anthony DiTonno, CEO of Tenax Therapeutics, talks about what’s on the horizon for financing and the...

January 22nd, 2019

Propanc’s Cancer Stem Cell Technology Ready for the Clinic

James Nathanielsz, CEO of Propanc Biopharma, talks about preclinical development, funding, cancer stem cells and more.

January 22nd, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Up During...

Axsome Therapeutics, Checkpoint Therapeutics, Bellerophon Therapeutics, Enochian Bioscience and Equillium were last week's top gainers.

January 13th, 2019

Notes from the Floor: Biotech Showcase, Day 2

The Biotech Showcase takes place in San Francisco from January 7 to 9. Here’s what happened...

January 8th, 2019

Verrica Releases Positive Phase 3 Results

Both trials achieved statistical significance for the primary objective with Verrica’s VP-102, a candidate for molluscum...

January 3rd, 2019

Big Pharma Collaboration Announced with Cocystal and Merck

Cocrystal Pharma and Merck have announced a new partnership that ignited investor attention in early trading...

January 3rd, 2019

Adamis Submits NDA for New Product

The application was for Adamis’ naloxone pre-filled single dose syringe (PFS) product candidate, as a treatment...

January 2nd, 2019

Get the latest Pharmaceutical Investing stock information

Get the latest information about companies associated with Pharmaceutical Investing Delivered directly to your inbox.

Pharmaceutical Investing

Select All
Select None

By selecting company or companies above, you are giving consent to receive communication from those companies using the contact information you provide. And remember you can unsubscribe at any time.